New hope for stubborn muscle disease? pilot test of arthritis drug shows promise
NCT ID NCT04431895
Summary
This small, early study tested whether a drug called tofacitinib could help adults with myasthenia gravis that doesn't respond well to standard treatments. Nineteen participants took the pill twice daily for four months, followed by a one-month observation period. Researchers measured changes in muscle weakness, daily function, and quality of life to see if the drug provided benefit.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYASTHENIA GRAVIS, GENERALIZED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huashan Hospital
Shanghai, 200040, China
Conditions
Explore the condition pages connected to this study.